ArticleMediterranean journal of hematology and infectious diseases2019

Relapsed/Refractory Chronic Lymphocytic Leukemia: Chemoimmunotherapy, Treatment until Progression with Mechanism-Driven Agents or Finite-Duration Therapy?

Antonio Cuneo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.